Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection

Abstract

Objective:

The choice of analgesia after cancer surgery may play a role in the onset of cancer recurrence. Particularly opioids seem to promote cancer cell proliferation and migration. Based on this consideration, we assessed the impact of perioperative analgesia choice on cancer recurrence after curative surgery for stage I non-small cell lung cancer (NSCLC).

Methods:

We retrospectively reviewed the records of all patients undergoing lung resection for stage I NSCLC between January 2005 and December 2012. Patients received analgesia either by peridural (PERI group) or intravenous analgesia with opioids (EV group). Follow-up was concluded in August 2019. Five-year cumulative incidence of recurrence and overall survival were evaluated and adjusted using a propensity score matching method.

Results:

A total of 382 patients were evaluated, 312 belonging to the PERI group (81.7%) and 70 to the EV group (18.3%). There was no statistically significant difference between the two groups in 5-year cumulative incidence of recurrence (p = 0.679) or overall survival rates (p = 0.767). These results were confirmed after adjustment for propensity score matching for cumulative incidence of recurrence (p = 0.925) or overall survival (p = 0.663).

Conclusions:

We found no evidence suggesting an association between perioperative analgesia choice and recurrence-free survival or overall survival in patients undergoing surgical resection of stage I NSCLC.

Keywords

Analgesia cancer NSCLC opioids peridural recurrence thoracic surgery

Get full access to this article

View all access options for this article.

References

Torre

Bray

Siegel

, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

Manser

Wright

Hart

, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 2005; Cd004699.

Postmus

Kerr

Oudkerk

, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28(suppl 4): iv1–iv21.

Horowitz

Neeman

Sharon

, et al. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 2015; 12: 213–226.

Tohme

Simmons

Tsung

. Surgery for cancer: a trigger for metastases. Cancer Res 2017; 77: 1548–1552.

Latif

Tan

Molena

, et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 2019; 157: 2469–2477.

Buggy

Borgeat

Cata

, et al. Consensus statement from the BJA Workshop on Cancer and Anaesthesia. Br J Anaesth 2015; 114: 2–3.

Missair

Cata

Votta-Velis

, et al. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Reg Anesth Pain Med 2019; 44: 13–28.

de Boer

Detriche

Forget

. Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering: a review of the literature. Best Pract Res Clin Anaesthesiol 2017; 31: 499–504.

10.

Cakmakkaya

Kolodzie

Apfel

, et al. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst Rev 2014; Cd008877.

11.

Wall

Sherwin

, et al. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth 2019; 123: 135–150.

12.

Boland

Pockley

. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol 2018; 175: 2726–2736.

13.

Lennon

Mirzapoiazova

Mambetsariev

, et al. Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 2012; 116: 857–867.

14.

Sacerdote

Bianchi

Gaspani

, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000; 90: 1411–1414.

15.

Roy

Barke

Loh

. Mu-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 1998; 61: 190–194.

16.

Desborough

. The stress response to trauma and surgery. Br J Anaesth 2000; 85: 109–117.

17.

The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resection. Clinicaltrials.gov; Unique identifier: NCT02840227.

18.

Regional Anesthesia and Lung Cancer Recurrence. ClinicalTrials.gov; Unique identifier: NCT01179308.

19.

von Elm

Altman

Egger

, et al; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344–349.

20.

Tai

Chan

, et al. Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study. BMJ Open 2019; 9: e027618.

21.

Sessler

Pei

Huang

, et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet 2019; 394: 1807–1815.

22.

Sun

Gan

. The effects of perioperative regional anesthesia and analgesia on cancer recurrence and survival after oncology surgery: a systematic review and meta-analysis. Reg Anesth Pain Med 2015; 40: 589–598.

23.

Tsigonis

Al-Hamadani

Linebarger

, et al. Are cure rates for breast cancer improved by local and regional anesthesia? Reg Anesth Pain Med 2016; 41: 339–347.

24.

Tseng

Kulkarni

Humphreys

, et al. Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study. Reg Anesth Pain Med 2014; 39: 284–288.

25.

Exadaktylos

Buggy

Moriarty

, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660–664.

26.

Biki

Mascha

Moriarty

, et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence:a retrospective analysis. Anesthesiology 2008; 109: 180–187.

27.

Cummings

3rd Xu

Cummings

, et al. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology 2012; 116: 797–806.

28.

Myles

Peyton

Silbert

, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 2011; 342: d1491.

29.

Cata

Zafereo

Villarreal

, et al. Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth 2015; 27: 672–679.

30.

Cata

Gottumukkala

Thakar

, et al. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth 2014; 26: 3–17.